Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with GoutThe New England journal of medicine, 2018-03, Vol.378 (13), p.1200-1210 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1710895 ;PMID: 29527974Full text available |
|
2 |
Material Type: Article
|
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factorsNature reviews. Rheumatology, 2020-07, Vol.16 (7), p.380-390 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/s41584-020-0441-1 ;PMID: 32541923Full text available |
|
3 |
Material Type: Article
|
Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort studyClinical and experimental rheumatology, 2023-03, Vol.41 (3), p.628-633 [Peer Reviewed Journal]ISSN: 0392-856X ;ISSN: 1593-098X ;EISSN: 1593-098X ;DOI: 10.55563/clinexprheumatol/eh0jcp ;PMID: 35930471Full text available |
|
4 |
Material Type: Article
|
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)Annals of the rheumatic diseases, 2017-05, Vol.76 (5), p.811-820 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-209213 ;PMID: 27821644 ;CODEN: ARDIAOFull text available |
|
5 |
Material Type: Article
|
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trialThe Lancet (British edition), 2020-11, Vol.396 (10264), p.1745-1757 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32234-0 ;PMID: 33181081Full text available |
|
6 |
Material Type: Article
|
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005Annals of the rheumatic diseases, 2008-07, Vol.67 (7), p.960-966 [Peer Reviewed Journal]2008 BMJ Publishing Group and European League Against Rheumatism ;2008 INIST-CNRS ;Copyright: 2008 2008 BMJ Publishing Group and European League Against Rheumatism ;Annemans et al 2008 2008 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2007.076232 ;PMID: 17981913 ;CODEN: ARDIAOFull text available |
|
7 |
Material Type: Article
|
National prevalence of gout derived from administrative health data in Aotearoa New ZealandRheumatology (Oxford, England), 2012-05, Vol.51 (5), p.901-909 [Peer Reviewed Journal]2015 INIST-CNRS ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/ker361 ;PMID: 22253023Full text available |
|
8 |
Material Type: Article
|
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemiaRheumatology (Oxford, England), 2014-12, Vol.53 (12), p.2167-2174 [Peer Reviewed Journal]The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/ket487 ;PMID: 24509406Full text available |
|
9 |
Material Type: Article
|
ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with goutThe pharmacogenomics journal, 2017-03, Vol.17 (2), p.201-203 [Peer Reviewed Journal]Copyright Nature Publishing Group Mar 2017 ;Macmillan Publishers Limited, part of Springer Nature. 2017. ;ISSN: 1470-269X ;EISSN: 1473-1150 ;DOI: 10.1038/tpj.2015.101 ;PMID: 26810134Full text available |
|
10 |
Material Type: Article
|
Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout studyAnnals of the rheumatic diseases, 2020-11, Vol.79 (11), p.1500-1505 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2020-217392 ;PMID: 32669301Full text available |
|
11 |
Material Type: Article
|
Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapyArthritis research & therapy, 2018-06, Vol.20 (1), p.108-108, Article 108 [Peer Reviewed Journal]COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-018-1596-x ;PMID: 29855389Full text available |
|
12 |
Material Type: Article
|
Gout, flares, and allopurinol use: a population-based studyArthritis research & therapy, 2019-05, Vol.21 (1), p.132-8, Article 132 [Peer Reviewed Journal]COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-019-1918-7 ;PMID: 31151457Full text available |
|
13 |
Material Type: Article
|
Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort studyArthritis research & therapy, 2018-10, Vol.20 (1), p.243-10, Article 243 [Peer Reviewed Journal]COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-018-1746-1 ;PMID: 30376864Full text available |
|
14 |
Material Type: Article
|
Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With GoutJournal of the American College of Cardiology, 2018-03, Vol.71 (9), p.994-1004 [Peer Reviewed Journal]2018 American College of Cardiology Foundation ;Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Mar 6, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.12.052 ;PMID: 29496000Full text available |
|
15 |
Material Type: Article
|
Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled studyArthritis research & therapy, 2018-05, Vol.20 (1), p.99-99, Article 99 [Peer Reviewed Journal]COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-018-1593-0 ;PMID: 29848361Full text available |
|
16 |
Material Type: Article
|
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trialArthritis research & therapy, 2010-01, Vol.12 (2), p.R63-R63 [Peer Reviewed Journal]COPYRIGHT 2010 BioMed Central Ltd. ;Copyright ©2010 Becker et al.; licensee BioMed Central Ltd. 2010 Becker et al.; licensee BioMed Central Ltd. ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/ar2978 ;PMID: 20370912Full text available |
|
17 |
Material Type: Article
|
Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapyCanadian Medical Association journal (CMAJ), 2019-06, Vol.191 (22), p.E597-E603 [Peer Reviewed Journal]2019 Joule Inc. or its licensors or its licensors ;2019 Joule Inc. or its licensors or its licensors. ;COPYRIGHT 2019 Joule Inc. ;Copyright Joule Inc Jun 3, 2019 ;2019 Joule Inc. or its licensors or its licensors 2019 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.180717 ;PMID: 31160496Full text available |
|
18 |
Material Type: Article
|
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety studyRheumatology (Oxford, England), 2009-02, Vol.48 (2), p.188-194 [Peer Reviewed Journal]The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org 2009 ;2009 INIST-CNRS ;The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/ken457 ;PMID: 19141576 ;CODEN: BJRHDFFull text available |
|
19 |
Material Type: Article
|
Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort StudyCirculation (New York, N.Y.), 2018-09, Vol.138 (11), p.1116-1126 [Peer Reviewed Journal]2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.033992 ;PMID: 29899013Full text available |
|
20 |
Material Type: Article
|
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with goutAnnals of the rheumatic diseases, 2017-09, Vol.76 (9), p.1522-1528 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-210872 ;PMID: 28314755Full text available |